D.E. Shaw & Co’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.9M | Buy |
791,305
+393,560
| +99% | +$10.9M | 0.02% | 669 |
|
|
2025
Q1 | $8.83M | Buy |
397,745
+77,738
| +24% | +$1.73M | 0.01% | 1065 |
|
|
2024
Q4 | $6.33M | Sell |
320,007
-990
| -0.3% | -$19.6K | ﹤0.01% | 1188 |
|
|
2024
Q3 | $8.02M | Buy |
320,997
+151,349
| +89% | +$3.78M | 0.01% | 1054 |
|
|
2024
Q2 | $3.17M | Sell |
169,648
-52,205
| -24% | -$975K | ﹤0.01% | 1503 |
|
|
2024
Q1 | $4.38M | Sell |
221,853
-82,752
| -27% | -$1.63M | ﹤0.01% | 1350 |
|
|
2023
Q4 | $5.34M | Sell |
304,605
-12,914
| -4% | -$227K | ﹤0.01% | 1194 |
|
|
2023
Q3 | $5.52M | Buy |
317,519
+78,919
| +33% | +$1.37M | 0.01% | 1136 |
|
|
2023
Q2 | $3.36M | Sell |
238,600
-1,188
| -0.5% | -$16.7K | ﹤0.01% | 1468 |
|
|
2023
Q1 | $2.58M | Buy |
239,788
+2,343
| +1% | +$25.2K | ﹤0.01% | 1710 |
|
|
2022
Q4 | $3.56M | Buy |
237,445
+125,274
| +112% | +$1.88M | ﹤0.01% | 1666 |
|
|
2022
Q3 | $1.44M | Buy |
112,171
+69,243
| +161% | +$889K | ﹤0.01% | 2329 |
|
|
2022
Q2 | $416K | Buy |
+42,928
| New | +$416K | ﹤0.01% | 3127 |
|
|
2022
Q1 | – | Sell |
-12,317
| Closed | -$145K | – | 4377 |
|
|
2021
Q4 | $145K | Buy |
+12,317
| New | +$145K | ﹤0.01% | 3577 |
|
|
2021
Q1 | – | Sell |
-50,089
| Closed | -$885K | – | 3067 |
|
|
2020
Q4 | $885K | Sell |
50,089
-52,297
| -51% | -$924K | ﹤0.01% | 2076 |
|
|
2020
Q3 | $1.57M | Buy |
102,386
+53,004
| +107% | +$812K | ﹤0.01% | 1717 |
|
|
2020
Q2 | $1.26M | Buy |
+49,382
| New | +$1.26M | ﹤0.01% | 1818 |
|
|
2019
Q3 | – | Sell |
-26,134
| Closed | -$354K | – | 2664 |
|
|
2019
Q2 | $354K | Sell |
26,134
-69,122
| -73% | -$936K | ﹤0.01% | 2251 |
|
|
2019
Q1 | $1.72M | Buy |
95,256
+85,714
| +898% | +$1.55M | ﹤0.01% | 1632 |
|
|
2018
Q4 | $268K | Buy |
+9,542
| New | +$268K | ﹤0.01% | 2290 |
|